Threadgill Financial’s Medtronic MDT Stock Holding History

Threadgill Financial’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,705	Closed	-$677K	–	45
2022 Q4	$677K	Buy	+8,705	New	+$706K	0.69%	27

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Threadgill Financial's MDT Position: Q1 2023 in Review

Threadgill Financial sold out of Medtronic (MDT) in Q1 2023, closing a stake of 8,705 shares — an estimated $677K sold.

Threadgill Financial first reported a position in MDT in Q4 2022 and held it in 1 quarter. The position peaked at $677K in Q4 2022. 1,990 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

Threadgill Financial reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
Threadgill Financial sold 8,705 Medtronic shares in Q1 2023, an estimated $677K.
Threadgill Financial first reported a position in Medtronic in Q4 2022 and held it in 1 quarter.
Threadgill Financial's Medtronic position peaked at $677K in Q4 2022.
1,990 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Threadgill Financial's 13F filing for Q1 2023, filed 13 Apr 2023.